Marshall Islands, Republic of the vs Nigeria: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Marshall Islands, Republic of the
62.0%
in 2025
Nigeria
62.0%
in 2025
Marshall Islands, Republic of the rank
142nd
Nigeria rank
142nd
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Marshall Islands, Republic of the
- Nigeria
How they compare
Marshall Islands, Republic of the currently reports 62.0% against 62.0% in Nigeria, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Nigeria ahead.
Marshall Islands, Republic of the ranks 142nd and Nigeria ranks 142nd of 192 countries.
Across the 3 decades both report, Marshall Islands, Republic of the averaged higher in 2 and Nigeria in 1.
Head to head by decade
| Decade | Marshall Islands, Republic of the | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.5% | 0.0% | 24.5% | Marshall Islands, Republic of the |
| 2010s | 51.4% | 26.1% | 25.3% | Marshall Islands, Republic of the |
| 2020s | 52.3% | 58.5% | 6.2% | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Marshall Islands, Republic of the or Nigeria?
- Marshall Islands, Republic of the, at 62.0% against 62.0% in Nigeria as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Marshall Islands, Republic of the and Nigeria?
- 0.0%, with Marshall Islands, Republic of the ahead.
- How many years of comparable data are there for Marshall Islands, Republic of the and Nigeria?
- 18 years are reported by both, from 2008 to 2025.
- How do Marshall Islands, Republic of the and Nigeria rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Marshall Islands, Republic of the ranks 142nd and Nigeria ranks 142nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.